Progress in laboratory testing of thyroid disease

Responses from Scientists working in clinical laboratories

These questions assessed from laboratory scientists, physicians, and patient organization, how satisfied they are with manufacturers policies on introducing new RIs as well as whether there was a risk-benefit analysis measures in place when switching from immunoassays to mass spectrometry methods.